Global Colorectal Cancer Molecular Diagnostics Market Size, Status and Forecast 2023-2027

Report ID: 920441 | Published Date: Mar 2024 | No. of Page: 106 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 PCR Diagnostics
        1.2.3 Mass spectrometry Diagnostics
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Colorectal Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Ambulatory Surgical Centers
        1.3.4 Diagnostic Laboratories
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Colorectal Cancer Molecular Diagnostics Market Perspective (2016-2027)
    2.2 Colorectal Cancer Molecular Diagnostics Growth Trends by Regions
        2.2.1 Colorectal Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Colorectal Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
        2.2.3 Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
    2.3 Colorectal Cancer Molecular Diagnostics Industry Dynamic
        2.3.1 Colorectal Cancer Molecular Diagnostics Market Trends
        2.3.2 Colorectal Cancer Molecular Diagnostics Market Drivers
        2.3.3 Colorectal Cancer Molecular Diagnostics Market Challenges
        2.3.4 Colorectal Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue
        3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Players by Revenue (2016-2021)
        3.1.2 Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
    3.2 Global Colorectal Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Colorectal Cancer Molecular Diagnostics Revenue
    3.4 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio
        3.4.1 Global Colorectal Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Revenue in 2020
    3.5 Colorectal Cancer Molecular Diagnostics Key Players Head office and Area Served
    3.6 Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
    3.7 Date of Enter into Colorectal Cancer Molecular Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Colorectal Cancer Molecular Diagnostics Breakdown Data by Type
    4.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
    4.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Colorectal Cancer Molecular Diagnostics Breakdown Data by Application
    5.1 Global Colorectal Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
    5.2 Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
    6.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Type
        6.2.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
        6.2.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
        6.2.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
    6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Application
        6.3.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
        6.3.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
        6.3.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
    6.4 North America Colorectal Cancer Molecular Diagnostics Market Size by Country
        6.4.1 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
        6.4.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
    7.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type
        7.2.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
        7.2.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
        7.2.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
    7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application
        7.3.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
        7.3.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
        7.3.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
    7.4 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country
        7.4.1 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
        7.4.2 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
    8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
    9.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type
        9.2.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
        9.2.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
        9.2.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
    9.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application
        9.3.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
        9.3.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
        9.3.3 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
    9.4 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country
        9.4.1 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
        9.4.2 Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size (2016-2027)
    10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Agilent
        11.1.1 Agilent Company Details
        11.1.2 Agilent Business Overview
        11.1.3 Agilent Colorectal Cancer Molecular Diagnostics Introduction
        11.1.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.1.5 Agilent Recent Development
    11.2 Hologic
        11.2.1 Hologic Company Details
        11.2.2 Hologic Business Overview
        11.2.3 Hologic Colorectal Cancer Molecular Diagnostics Introduction
        11.2.4 Hologic Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.2.5 Hologic Recent Development
    11.3 Qiagen
        11.3.1 Qiagen Company Details
        11.3.2 Qiagen Business Overview
        11.3.3 Qiagen Colorectal Cancer Molecular Diagnostics Introduction
        11.3.4 Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.3.5 Qiagen Recent Development
    11.4 Roche
        11.4.1 Roche Company Details
        11.4.2 Roche Business Overview
        11.4.3 Roche Colorectal Cancer Molecular Diagnostics Introduction
        11.4.4 Roche Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.4.5 Roche Recent Development
    11.5 Bayer
        11.5.1 Bayer Company Details
        11.5.2 Bayer Business Overview
        11.5.3 Bayer Colorectal Cancer Molecular Diagnostics Introduction
        11.5.4 Bayer Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.5.5 Bayer Recent Development
    11.6 Abbott
        11.6.1 Abbott Company Details
        11.6.2 Abbott Business Overview
        11.6.3 Abbott Colorectal Cancer Molecular Diagnostics Introduction
        11.6.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.6.5 Abbott Recent Development
    11.7 Grifols
        11.7.1 Grifols Company Details
        11.7.2 Grifols Business Overview
        11.7.3 Grifols Colorectal Cancer Molecular Diagnostics Introduction
        11.7.4 Grifols Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.7.5 Grifols Recent Development
    11.8 Danaher
        11.8.1 Danaher Company Details
        11.8.2 Danaher Business Overview
        11.8.3 Danaher Colorectal Cancer Molecular Diagnostics Introduction
        11.8.4 Danaher Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.8.5 Danaher Recent Development
    11.9 Siemens
        11.9.1 Siemens Company Details
        11.9.2 Siemens Business Overview
        11.9.3 Siemens Colorectal Cancer Molecular Diagnostics Introduction
        11.9.4 Siemens Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.9.5 Siemens Recent Development
    11.10 BD
        11.10.1 BD Company Details
        11.10.2 BD Business Overview
        11.10.3 BD Colorectal Cancer Molecular Diagnostics Introduction
        11.10.4 BD Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.10.5 BD Recent Development
    11.11 Biomérieux
        11.11.1 Biomérieux Company Details
        11.11.2 Biomérieux Business Overview
        11.11.3 Biomérieux Colorectal Cancer Molecular Diagnostics Introduction
        11.11.4 Biomérieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.11.5 Biomérieux Recent Development
    11.12 Sysmex
        11.12.1 Sysmex Company Details
        11.12.2 Sysmex Business Overview
        11.12.3 Sysmex Colorectal Cancer Molecular Diagnostics Introduction
        11.12.4 Sysmex Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
        11.12.5 Sysmex Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Colorectal Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of PCR Diagnostics
    Table 3. Key Players of Mass spectrometry Diagnostics
    Table 4. Key Players of Others
    Table 5. Global Colorectal Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Colorectal Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Colorectal Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Colorectal Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
    Table 9. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Colorectal Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
    Table 11. Colorectal Cancer Molecular Diagnostics Market Trends
    Table 12. Colorectal Cancer Molecular Diagnostics Market Drivers
    Table 13. Colorectal Cancer Molecular Diagnostics Market Challenges
    Table 14. Colorectal Cancer Molecular Diagnostics Market Restraints
    Table 15. Global Colorectal Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Colorectal Cancer Molecular Diagnostics Market Share by Players (2016-2021)
    Table 17. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2020)
    Table 18. Ranking of Global Top Colorectal Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Colorectal Cancer Molecular Diagnostics Product Solution and Service
    Table 22. Date of Enter into Colorectal Cancer Molecular Diagnostics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
    Table 26. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Colorectal Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
    Table 30. Global Colorectal Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Agilent Company Details
    Table 63. Agilent Business Overview
    Table 64. Agilent Colorectal Cancer Molecular Diagnostics Product
    Table 65. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 66. Agilent Recent Development
    Table 67. Hologic Company Details
    Table 68. Hologic Business Overview
    Table 69. Hologic Colorectal Cancer Molecular Diagnostics Product
    Table 70. Hologic Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 71. Hologic Recent Development
    Table 72. Qiagen Company Details
    Table 73. Qiagen Business Overview
    Table 74. Qiagen Colorectal Cancer Molecular Diagnostics Product
    Table 75. Qiagen Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 76. Qiagen Recent Development
    Table 77. Roche Company Details
    Table 78. Roche Business Overview
    Table 79. Roche Colorectal Cancer Molecular Diagnostics Product
    Table 80. Roche Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 81. Roche Recent Development
    Table 82. Bayer Company Details
    Table 83. Bayer Business Overview
    Table 84. Bayer Colorectal Cancer Molecular Diagnostics Product
    Table 85. Bayer Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 86. Bayer Recent Development
    Table 87. Abbott Company Details
    Table 88. Abbott Business Overview
    Table 89. Abbott Colorectal Cancer Molecular Diagnostics Product
    Table 90. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 91. Abbott Recent Development
    Table 92. Grifols Company Details
    Table 93. Grifols Business Overview
    Table 94. Grifols Colorectal Cancer Molecular Diagnostics Product
    Table 95. Grifols Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 96. Grifols Recent Development
    Table 97. Danaher Company Details
    Table 98. Danaher Business Overview
    Table 99. Danaher Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 100. Danaher Recent Development
    Table 101. Siemens Company Details
    Table 102. Siemens Business Overview
    Table 103. Siemens Colorectal Cancer Molecular Diagnostics Product
    Table 104. Siemens Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 105. Siemens Recent Development
    Table 106. BD Company Details
    Table 107. BD Business Overview
    Table 108. BD Colorectal Cancer Molecular Diagnostics Product
    Table 109. BD Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 110. BD Recent Development
    Table 111. Biomérieux Company Details
    Table 112. Biomérieux Business Overview
    Table 113. Biomérieux Colorectal Cancer Molecular Diagnostics Product
    Table 114. Biomérieux Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 115. Biomérieux Recent Development
    Table 116. Sysmex Company Details
    Table 117. Sysmex Business Overview
    Table 118. Sysmex Colorectal Cancer Molecular Diagnostics Product
    Table 119. Sysmex Revenue in Colorectal Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
    Table 120. Sysmex Recent Development
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Colorectal Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
    Figure 2. PCR Diagnostics Features
    Figure 3. Mass spectrometry Diagnostics Features
    Figure 4. Others Features
    Figure 5. Global Colorectal Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Ambulatory Surgical Centers Case Studies
    Figure 8. Diagnostic Laboratories Case Studies
    Figure 9. Colorectal Cancer Molecular Diagnostics Report Years Considered
    Figure 10. Global Colorectal Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Colorectal Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Colorectal Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
    Figure 13. Global Colorectal Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
    Figure 14. Global Colorectal Cancer Molecular Diagnostics Market Share by Players in 2020
    Figure 15. Global Top Colorectal Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colorectal Cancer Molecular Diagnostics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Colorectal Cancer Molecular Diagnostics Revenue in 2020
    Figure 17. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
    Figure 18. Global Colorectal Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
    Figure 19. North America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 21. North America Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 22. North America Colorectal Cancer Molecular Diagnostics Market Share by Country (2016-2027)
    Figure 23. United States Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 27. Europe Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 28. Europe Colorectal Cancer Molecular Diagnostics Market Share by Country (2016-2027)
    Figure 29. Germany Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Share by Region (2016-2027)
    Figure 39. China Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 47. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 48. Latin America Colorectal Cancer Molecular Diagnostics Market Share by Country (2016-2027)
    Figure 49. Mexico Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Share by Country (2016-2027)
    Figure 55. Turkey Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Colorectal Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Agilent Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 59. Hologic Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 60. Qiagen Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 61. Roche Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 62. Bayer Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 63. Abbott Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 64. Grifols Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 65. Danaher Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 66. Siemens Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 67. BD Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 68. Biomérieux Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 69. Sysmex Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Business (2016-2021)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Agilent
Hologic
Qiagen
Roche
Bayer
Abbott
Grifols
Danaher
Siemens
BD
Biomérieux
Sysmex
Frequently Asked Questions
Colorectal Cancer Molecular Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Colorectal Cancer Molecular Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Colorectal Cancer Molecular Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports